Bethesda conference: Conference for the design of clinical trials to study circulatory support devices for chronic heart failure

Annals of Thoracic Surgery

Volumn 66, Issue 4, 1998, Pages 1452-1465

  Pae Jr , Walter E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSISTED CIRCULATION; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; DEVICE; EXERCISE; FUNCTIONAL ASSESSMENT; HEART FAILURE; ORGAN DONOR; PRIORITY JOURNAL; QUALITY OF LIFE;

CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; RESEARCH DESIGN;

EID: 0032192015     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01375-1     Document Type: Conference Paper

References (82)

1. 1. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation. Semin Thorac Surg 1994;6:174-80.
2. 2. Frazier OH, Radovancevic B, Abou-Awdi NL, et al. Ventricular remodeling after prolonged ventricular unloading: "heart rest" experience with the HeartMate left ventricular assist device. J Heart Lung Transplant [Abstract]. 1994;13: S51.
3. 3. McCarthy PM, Nakatani S, Vargo R, et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995;59:609-13.
4. 4. Levin HR, Oz MC, Chen JM, et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995; 91:2717-20.
5. 5. Charron M, Follansbee W, Ziady GM, Kormos RL. Assessment of biventricular cardiac function in patients with a Novacor left ventricular assist device. J Heart Lung Transplant 1994;13:263-7.
6. 6. Chow E, Farrar DJ. Right heart function during prosthetic left ventricular assistance in a porcine model of congestive heart failure. J Thorac Cardiovasc Surg 1992;104:569-78.
7. 7. Pennington DG, Reedy JE, Swartz MT, et al. Univentricular versus biventricular assist device support. J Heart Lung Transplant 1991;10:258-63.
8. 8. Chow E, Farrar DJ. Effects of left ventricular pressure reductions on right ventricular systolic performance. Am J Physiol 1989;257(6, pt 2):H1878-85.
9. 9. Farrar DJ. Ventricular interactions during mechanical circulatory support. Semin Thorac Cardiovasc Surg 1994;6:163-8.
10. 10. Mandarino WA, Morita S, Kormos RL, et al. Quantitation of right ventricular shape changes after left ventricular assist device implantation. ASAIO J 1992;38:M228-31.
11. 11. Mandarine WA, Gorcsan J III, Armitage JM, Griffith BP, Kormos RL. Assessment of the response of right ventricular performance to decreasing levels of mechanical assistance by on-line pressure area relationships. ASAIO J 1994;40: 1032-5.
12. 12. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992;53:1080-90.
13. 13. Kormos RL, Gasior TA, Kawai A, et al. Transplant candidate's clinical status rather than right ventricular (RV) function defines need for univentricular vs. biventricular support. J Thorac Cardiovasc Surg 1996;111:773-83.
14. 14. Levin HR, Burkhoff D, Oz MC, et al. Pre-operative right ventricular stroke work is a major determinant of right heart failure in patients after left ventricular assist device implantation. J Heart Lung Transplant 1994;13(Suppl 1):S73.
15. 15. Kormos RL, Gasior T, Antaki J, et al. Evaluation of right ventricular function during clinical left ventricular assistance. ASAIO Trans 1989;35:547-50.
16. 16. McCarthy PM, Savage RM, Fraser CD, et al. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg 1995;109:409-18.
17. 17. Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1994;57:51-8.
18. 18. Burnett CM, Duncan MJ, Frazier OH, et al. Improved multiorgan function after prolonged univentricular support. Ann Thorac Surg 1993;55:65-71.
19. 19. Wang I, Kottke-Marchant K, Vargo RL, McCarthy PM. Hemostatic profiles of HeartMate ventricular assist device recipients. ASAIO J 1995;41:M782-7.
20. 20. Jaski BE, Branch KR, Adamson R, et al. Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation. J Am Coll Cardiol 1993;22:1574-80.
21. 21. Branch KR, Dembitsky WP, Peterson KL, et al. Physiology of the native heart and ThermoCardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support. J Heart Lung Transplant 1994;13: 641-51.
22. 22. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62:675-82.
23. 23. Mandarine WA, Gorcsan J III, Gasior TA, et al. Estimation of left ventricular function in patients with a left ventricular assist device. ASAIO J 1995;41:M544-7.
24. 24. Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis: results of a multicenter trial. Am J Med 1986;81:565-78.
25. 25. Bulpitt CJ, Fletcher AE. Quality of life evaluation of antihypertensive drugs. PharmacoEconomics 1992;1:95-102.
26. 26. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314:1657-64.
27. 27. Dew MA, Harris RC, Simmons RG, Roth LH, Armitage JM, Griffith BP. Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation. Transplant Proc 1991;23:3061-4.
28. 28. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407-13.
29. 29. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27:S217-32.
30. 30. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. Quality of life and antihypertensive therapy in men: a comparison of captopril with enalapril. N Engl J Med 1993;328: 907-13.
31. 31. Wilson IR, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995;273:59-65.
32. 32. Bulpitt CJ, Fletcher AE. Measurement of the quality of life in congestive heart failure - influence of drug therapy. Cardiovasc Drugs Ther 1988;2:419-24.
33. 33. Canadian Erthropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990;300:575-8.
34. 34. Cleary PD, Epstein AM, Oster G, et al. Health-related quality of life among patients undergoing percutaneous transluminal coronary angioplasty. Med Care 1991;29:939-50.
35. 35. Eschbach JW, Abdulhadi MH, Browne JK, et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease: results of a phase III multicenter clinical trial. Ann Intern Med 1989;111:992-1000.
36. 36. Evans RW. The economics of heart transplantation. Circulation 1987;75:63-76.
37. 37. Evans RW. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis. Am J Kidney Dis 1991;18(Suppl 1):62-70.
38. 38. Evans RW. Quality of life assessment and the treatment of end-stage renal disease. Transplant Rev 1990;4:1-23.
39. 39. Evans RW. Psychosocial aspects of heart transplantation. In: Walter PJ, ed. Quality of life after open heart surgery. Dordrecht, the Netherlands: Kluwer Academic, 1992:469-82.
40. 40. McMillem C, Fiegl P, Metch B, Hayden KA, Meyskens FL, Crowley J. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 1989;81: 485-95.
41. 41. Rogers WJ, Johnstone DE, Yusuf S, et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. J Am Coll Cardiol 1994;23:393-400.
42. 42. Tarlov AR. Outcomes assessment and quality of life in patients with human immunodeficiency virus infection. Ann Intern Med 1992;116:166-7.
43. 43. Testa MA, Nackley JF. Methods for quality-of-life studies. Annu Rev Public Health 1994;15:535-59.
44. 44. Avis NE, Czajkowski SM, Dew MA, et al. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure: measuring quality of life. ASAIO J 1995;41:32-41.
45. 45. Health-related quality of life: a review of findings from NHLBI-supported clinical research. National Heart, Lung, and Blood Institute. US Government Printing Office, 1995.
46. 46. Schron EB, Gorkin L, Garg R. Evaluating quality of life in congestive heart failure: issues, progress, and recommendations. In: GT Kennedy, MH Crawford, eds. Congestive heart failure: current clinical issues. Armonk, NY: Futura, 1994.
47. 47. Schron EB, Shumaker SA. The integration of health quality of life in clinical research: experiences from cardiovascular clinical trials. Prog Cardiovasc Nurs 1991;7:21-8.
48. 89. Freedberg KA, Tosteson ANA, Cohen CJ, Cotton DJ. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200: a cost-effectiveness analysis. J Acquir Immune Defic Syndr 1991;4: 521-31.
49. 49. Gelber RD, Goldhirsch A. A new endpoint for the assessment of adjuvant therapy in post menopausal women with operable breast cancer. J Clin Oncol 1986;4:1772-9.
50. 50. Their SO. Forces motivating the use of health status assessment measures in clinical settings and related clinical research. Med Care 1992;30:MS15-22.
51. 51. Recombinant human erythropoietin: payment options for Medicare. Washington, DC: Office of Technology Assessment, 1990. US Government Printing Office publication OTA-H-451.
52. 52. Sisk JE, Gianfrancesco FD, Coster JM. Medicare payment options for recombinant erythropoietin therapy. Am J Kidney Dis 1991;18(Suppl 1):93-7.
53. 53. Constitution in basic documents. Geneva: World Health Organization, 1948.
54. 54. Dew MA, Kormos RL, Roth LH, et al. Life quality in the era of bridging to cardiac transplantation: bridge patients in an outpatient setting. ASAIO J 1993;39:145-52.
55. 55. Dew MA, Simmons RG. The advantage of multiple measures of quality of life. Scand J Urol Nephrol 1990;131 (Suppl):23-30.
56. 56. Walter J, Shannon T, eds. Quality of life. The new medical dilemma. NY: Paulist Press, 1990.
57. 57. Stewart AL, Ware JE, eds. Measuring functioning and well-being: the medical outcomes study approach. Durham, NC: Duke University Press, 1992.
58. 58. Dew MA, Kormos RL, Nastala C, et al. Psychiatric and psychosocial issues and intervention among ventricular assist device patients. In: Albert W, Bittner A, Hetzer R, eds. Quality of life and psychosomatics in mechanical circulation and heart transplantation. Darmstadt, Germany: Steinkopff Verlag, 1998:17-27.
59. 59. Bunzel B, Grundböck A, Laczkovics A, Holzinger C, Teufelsbauer H. Quality of life after orthotopic heart transplantation. J Heart Lung Transplant 1991;10:455-9.
60. 60. Jones BM, Taylor F, Downs K, Spratt P. Longitudinal study of quality of life and psychological adjustment after cardiac transplantation. Med J Aust 1992;157:24-6.
61. 61. Lough ME, Lindsey AM, Shinn JA, Stotts NA. Life satisfaction following heart transplantation. J Heart Transplant 1985; 4:446-9.
62. 62. Mai FM, McKenzie FN, Kostuk WJ. Psychosocial adjustment and quality of life following heart transplantation. Can J Psychiat 1990;35:223-7.
63. 63. O'Brien BJ, Buxton MJ, Ferguson BA. Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis. J Chronic Dis 1987;40:137S-53S.
64. 64. Samuelsson RG, Hunt SA, Schroeder JS. Functional and social rehabilitation of heart transplant recipients under age thirty. Scand J Thorac Cardiovasc Surg 1984;18:97-103.
65. 65. Shapiro PA, Levin H, Oz M. Left ventricular assist devices: psychosocial burden and implications for heart transplant programs. Presented at the Third Biennial Conference on Psychiatric, Psychosocial and Ethical Issues in Organ Transplantation, Richmond, VA, Oct 1994.
66. 66. Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1990;57:51-8.
67. 67. Levin HR, Chen JM, Oz MC, et al. Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg 1994;58:1515-20.
68. 68. Myers TJ, Dasse KA, Macris MP, Poirier VL, Cloy MJ, Frazier LH. Use of a left ventricular assist device in an outpatient setting. ASAIO J 1994;40:M471-5.
69. 69. Kendell K, McCarthy PM, Sharp JW, Vargo RL. Quality of life for hospitalized implantable left ventricular assist device patients. Presented at the Annual Meeting of the International Society for Heart and Lung Transplantation, Venice, 1993.
70. 70. Eidelman BH, Obrist WD, Wagner WR, Kormos R, Griffith B. Cerebrovascular complications associated with the use of artificial circulatory support services. Neurocardiol 1993;11: 463-74.
71. 71. Ruzevich SA, Swartz MT, Reedy JE, et al. Retrospective analysis of the psychologic effects of mechanical circulatory support. J Heart Transplant 1990;9:209-12.
72. 72. Williams BA, Lough ME, Shinn JA. Left ventricular assist device as a bridge to heart transplantation: a case study. J Heart Transplant 1987;6:23-8.
73. 73. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-83.
74. 74. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston, MA: The Health Institute, 1994.
75. 75. Bergner M, Bobbitt RA, Carter W, Gilson B. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
76. 76. Lezak MD. Neuropsychological assessment, 2nd ed. New York: Oxford University Press, 1983.
77. 77. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data: application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry 1993; 50:739-50.
78. 78. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986;42:805-20.
79. 79. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. NY: Oxford University Press, 1996.
80. 80. Wenger NK, Mattson ME, Furberg CD, Elinson J, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: LeJacq, 1984.
81. 81. Wechsler D. Wechsler Adult Intelligence Scale - third edition. San Antonio, TX: Psychological Corporation, 1997.
82. 82. Dew MA, Kormos RL, Winowich S, et al. Quality of life outcomes in left ventricular assist system inpatients and outpatients. Presented at the Annual Meeting of the American Society for Artificial Internal Organs, New York, NY, April 1998.